A systematic review of the diagnosis and treatment of primary hyperparathyroidism from 1995 to 2003

被引:530
作者
Ruda, JM
Hollenbeak, CS
Stack, BC
机构
[1] Penn State Coll Med, Dept Surg, Hershey, PA 17033 USA
[2] Penn State Coll Med, Dept Hlth Evaluat Sci, Hershey, PA USA
[3] Penn State Coll Med, Div Otolaryngol Head & Neck Surg, Hershey, PA USA
[4] Lehigh Valley Hosp, Dept Hlth Studies, Allentown, PA USA
关键词
D O I
10.1016/j.otohns.2004.10.005
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
OBJECTIVE. To systematically review the current preoperative diagnostic modalities, surgical treatments, and glandular pathologies associated with primary hyperparathyroidism. STUDY DESIGN. A systematic literature review. RESULTS: Of the 20,225 cases of primary hyperparathyroidism reported, solitary adenomas (SA), multiple gland hyperplasia disease (MGHD), double adenomas (DA), and parathyroid carcinomas (CAR) occurred in 88.90%, 5.74%, 4.14%, and 0.74% of cases respectively. Tc-99m-sestamibi and ultrasound were 88.44% and 78.55% sensitive, respectively, for SA, 44.46% and 34.86% for MGHD, and 29.95% and 16.20% for DA, respectively. Postoperative normocalcemia was achieved in 96.66%, 95.25%, and 97.69% of patients offered minimally invasive radio-guided parathyroidectomy (MIRP), unilateral, and bilateral neck exploration (BNE). Intraoperative PTH assays (IOPTH) were helpful in approximately 60% of bilateral neck exploration conversion (BNEC) surgeries. CONCLUSION: The overall prevalence of multiple gland disease (MGD and DA) was lower than often suggested by conventional wisdom. Furthermore, preoperative imaging was less accurate than it is often perceived for accurately imaging MGD. MIRP and UNE were more successful in achieving normocalcemia than is typically quoted. IOPTH was a helpful but not "fool-proof" adjunct in parathyroid exploration surgery. SIGNIFICANCE: These results support a greater role for the treatment of primary hyperparathyroidism using less invasive approaches.
引用
收藏
页码:359 / 372
页数:14
相关论文
共 227 条
  • [61] Ditkoff BA, 1996, AM J SURG, V172, P698
  • [62] Ebisuno S, 1997, Int J Urol, V4, P126, DOI 10.1111/j.1442-2042.1997.tb00157.x
  • [63] Falvo L, 2002, PANMINERVA MED, V44, P3
  • [64] Transient rise in intact parathyroid hormone concentration after surgery for parathyroid adenoma
    Ferrer-Ramirez, MJ
    Domingo, MA
    López-Mollá, C
    Izquierdo, ES
    Pastor, SG
    Ariño, CM
    Mijares, AH
    [J]. OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2003, 128 (06) : 771 - 776
  • [65] Fjeld JG, 1997, J NUCL MED, V38, P831
  • [66] Primary hyperparathyroidism: Referral patterns and outcomes of surgery
    Flint, RS
    Harman, CR
    Carter, J
    Snyman, G
    [J]. ANZ JOURNAL OF SURGERY, 2002, 72 (03) : 200 - 203
  • [67] Minimally invasive radioguided parathyroidectomy
    Flynn, MB
    Bumpous, JM
    Schill, K
    McMasters, KM
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2000, 191 (01) : 24 - 31
  • [68] Gallowitsch HJ, 1997, NUKLEARMED, V36, P13
  • [69] Initial experience with intraoperative PTH determinations in the surgical management of 130 consecutive cases of primary hyperparathyroidism
    Garner, SC
    Leight, GS
    [J]. SURGERY, 1999, 126 (06) : 1132 - 1137
  • [70] Intraoperative parathyroid hormone monitoring fails to detect double parathyroid adenomas: A 2-institution experience
    Gauger, PG
    Agarwal, G
    England, BG
    Delbridge, LW
    Matz, KA
    Wilkinson, M
    Robinson, BG
    Thompson, NW
    [J]. SURGERY, 2001, 130 (06) : 1005 - 1010